Clinical Trial Update: Ripertamab for the Treatment of Myasthenia Gravis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trial update for Ripertamab in Myasthenia Gravis. The study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• Ripertamab

Snippet

Sponsor: Zhongming Qiu | Conditions: Myasthenia Gravis (MG) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING